Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation

Obstetrics and Gynecology

Volumn 110, Issue 5, 2007, Pages 1041-1049

  Stratton, Pamela ^a,b   Turner, Maria L ^b   Childs, Richard ^b   Barrett, John ^b   Bishop, Michael ^b   Wayne, Alan S ^b   Pavletic, Steven ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b MSC 1109 ^*

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CLOBETASOL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DACLIZUMAB; ESTRADIOL; ESTROGEN; FLUDARABINE; GLUCOCORTICOID; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; ERYTHEMA; FEMALE; HUMAN; MENOPAUSE; OBSERVATIONAL STUDY; PAIN; PRIORITY JOURNAL; SCAR FORMATION; SEXUAL INTERCOURSE; TREATMENT OUTCOME; VAGINA RING; VULVA DISEASE; VULVAR VESTIBULITIS; VULVOVAGINAL DISEASE;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; COHORT STUDIES; ESTROGENS; FEMALE; GLUCOCORTICOIDS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; VULVOVAGINITIS;

EID: 35848962706     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000285998.75450.86     Document Type: Article

References (19)

1. Bhushan V, Collins Jr. RH Chronic graft-vs-host disease. JAMA 2003;290:2599-603.
2. Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002;100:415-9.
3. Pavletic ZS, Bishop MR, Tarantolo SR, Martin-Algarra S, Bierman PJ, Vose JM, et al. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. J Clin Oncol 1997;15:1608-16.
4. Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza FR Jr, Ringden O, et al. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol 2004;22:4872-80.
5. Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005;23:5074-87.
6. Corson SL, Sullivan K, Batzer F, August C, Storb R, Thomas ED. Gynecologic manifestations of chronic graft-versus-host disease. Obstet Gynecol 1982;60:488-92.
7. Spinelli S, Chiodi S, Costantini S, Van Lint MT, Raiola AM, Ravera GB, et al. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Haematologica 2003;88:1163-8.
8. Zantomio D, Grigg AP, Macgregor L, Panek-Hudson Y, Szer J, Ayton R. Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management. Bone Marrow Transplant 2006;38:567-72.
9. Prussick R, Horn TD, Wilson WH, Turner MC. A characteristic eruption associated with ifosfamide, carboplatin, and etoposide chemotherapy after pretreatment with recombinant interleukin-1 alpha. J Am Acad Dermatol 1996;35:705-9.
10. Marinoff SC, Turner ML. Vulvar vestibulitis syndrome. Dermatol Clin 1992;10:435-44.
11. Slavin S. Graft-versus-host disease, the graft-versus-leukemia effect, and mixed chimerism following nonmyeloablative stem cell transplantation. Int J Hematol 2003;78:195-207.
12. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005;11:945-56.
13. Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006;12:31-47.
14. Spiryda LB, Laufer MR, Soiffer RJ, Antin JA. Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment. Biol Blood Marrow Transplant 2003;9:760-5.
15. Yanai N, Shufaro Y, Or R, Meirow D. Vaginal outflow tract obstruction by graft-versus-host reaction. Bone Marrow Transplant 1999;24:811-2.
16. DeLord C, Treleaven J, Shepherd J, Saso R, Powles RL. Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia. Bone Marrow Transplant 1999;23:523-5.
17. Gossett DR, Montz FJ, Bristow RE. Cystic paracervical mass as an unusual sequela of graft-versus-host disease. A case report. J Reprod Med 2002;47:600-2.
18. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
19. Barrett-Connor E, Grady D, Stefanick ML. The rise and fall of menopausal hormone therapy. Annu Rev Public Health 2005;26:115-40.